Your browser doesn't support javascript.
loading
ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: A Randomized, Double-Blind Study.
Genovese, Mark C; Weinblatt, Michael E; Aelion, Jacob A; Mansikka, Heikki T; Peloso, Paul M; Chen, Kun; Li, Yihan; Othman, Ahmed A; Khatri, Amit; Khan, Nasser S; Padley, Robert J.
Afiliação
  • Genovese MC; Stanford University Medical Center, Palo Alto, California.
  • Weinblatt ME; Brigham and Women's Hospital, Boston, Massachusetts.
  • Aelion JA; University of Tennessee Heath Science Center, Memphis, Tennessee.
  • Mansikka HT; AbbVie Incorporated, North Chicago, Illinois.
  • Peloso PM; AbbVie Incorporated, North Chicago, Illinois.
  • Chen K; AbbVie Incorporated, North Chicago, Illinois.
  • Li Y; AbbVie Incorporated, North Chicago, Illinois.
  • Othman AA; AbbVie Incorporated, North Chicago, Illinois.
  • Khatri A; AbbVie Incorporated, North Chicago, Illinois.
  • Khan NS; AbbVie Incorporated, North Chicago, Illinois.
  • Padley RJ; AbbVie Incorporated, North Chicago, Illinois.
Arthritis Rheumatol ; 70(11): 1710-1720, 2018 11.
Article em En | MEDLINE | ID: mdl-29855172

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Imunoglobulinas / Fator de Necrose Tumoral alfa / Antirreumáticos / Interleucina-17 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Imunoglobulinas / Fator de Necrose Tumoral alfa / Antirreumáticos / Interleucina-17 Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2018 Tipo de documento: Article